RobertJOrlowskiMD

Physician

Dr. Orlowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Spruce St
Philadelphia, PA 19104
Phone+1 215-662-2200

Fax+1 215-349-8144

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2013 - 2016
University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
University of Cincinnati College of MedicineClass of 2010

PubMed

20 citations
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma.
Payal D Shah, Alexander C Huang, Xiaowei Xu, Robert Orlowski, Ravi K Amaravadi
Cancer Research Communications. 2023-05-01
463 citations
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
Alexander C. Huang, Robert J. Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George
Nature Medicine. 2019-02-25
1159 citations
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang, Michael A. Postow, Robert J. Orlowski, Rosemarie Mick, Bertram Bengsch
Nature. 2017-05-04

Lectures

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 StudiesClinically Re...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrom Macroglobulinemia, and Amyloidosis
60th American Society of Hematology Annual Meeting - 11/30/2018